Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, Rule 144(i).
Appears in 421 contracts
Samples: Securities Purchase Agreement (Top KingWin LTD), Securities Purchase Agreement (EShallGo Inc.), Securities Purchase Agreement (Top KingWin LTD)
Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, in Rule 144(i144(i)(1).
Appears in 270 contracts
Samples: Securities Purchase Agreement (Berkshire Hills Bancorp Inc), Securities Purchase Agreement (Wesbanco Inc), Securities Purchase Agreement (KALA BIO, Inc.)
Shell Company Status. The Company is notnot currently, and has never been, an issuer identified in, or subject to, in Rule 144(i)144(i)(1) under the Securities Act.
Appears in 121 contracts
Samples: Securities Purchase Agreement (Avalo Therapeutics, Inc.), Securities Purchase Agreement (Adverum Biotechnologies, Inc.), Securities Purchase Agreement (Outlook Therapeutics, Inc.)
Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, in Rule 144(i)144(i)(1) of the Securities Act.
Appears in 51 contracts
Samples: Warrant Agreement (Personalis, Inc.), Warrant Agreement (Personalis, Inc.), Stock Purchase Agreement (Southern States Bancshares, Inc.)
Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, in Rule 144(i)144(i)(1) under the Securities Act.
Appears in 50 contracts
Samples: Implementation Agreement (PowerFleet, Inc.), Investment Agreement (Third Coast Bancshares, Inc.), Purchase Agreement (Freeline Therapeutics Holdings PLC)
Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, Rule 144(i)144(i)(1) of the Securities Act.
Appears in 28 contracts
Samples: Purchase Agreement (Sadot Group Inc.), Securities Purchase Agreement (Olema Pharmaceuticals, Inc.), Securities Purchase Agreement (Digital Ally, Inc.)
Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, Rule 144(i)) of the Securities Act.
Appears in 24 contracts
Samples: Exchange Agreement (Kiromic Biopharma, Inc.), Exchange Agreement (Kiromic Biopharma, Inc.), Exchange Agreement (Origin Life Sciences, Inc.)
Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, of the type described in paragraph (i) of Rule 144(i)144.
Appears in 21 contracts
Samples: Securities Purchase Agreement (Meta Financial Group Inc), Securities Purchase Agreement (Meta Financial Group Inc), Securities Purchase Agreement (Meta Financial Group Inc)
Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, in Rule 144(i)144(i)(1) of the 1933 Act.
Appears in 21 contracts
Samples: Securities Purchase Agreement (Bandera Partners LLC), Securities Purchase Agreement (Vallon Pharmaceuticals, Inc.), Securities Purchase Agreement (Innovative Food Holdings Inc)
Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, Rule 144(i)144(i)(1) of the 1933 Act.
Appears in 16 contracts
Samples: Securities Purchase Agreement (Jeffs' Brands LTD), Common Stock Purchase Agreement (Liquidia Corp), Common Stock Purchase Agreement (Liquidia Corp)
Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, Rule 144(i)) promulgated under the Securities Act.
Appears in 10 contracts
Samples: Share Purchase Agreement (Tsakos Energy Navigation LTD), Purchase Agreement (Oncobiologics, Inc.), Exchange Agreement (Oncobiologics, Inc.)
Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, Rule 144(i)) promulgated under the 1933 Act.
Appears in 7 contracts
Samples: Securities Purchase Agreement (Arcimoto Inc), Backstop Agreement (CorMedix Inc.), Securities Purchase Agreement (CorMedix Inc.)
Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, Rule 144(i)) under the Securities Act.
Appears in 7 contracts
Samples: Purchase Agreement (Agrify Corp), Purchase Agreement (Remark Holdings, Inc.), Purchase Agreement (Logiq, Inc.)
Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, in Rule 144(i144(i)(l).
Appears in 6 contracts
Samples: Securities Purchase Agreement (Grandsouth Bancorporation), Securities Purchase Agreement (Origin Bancorp, Inc.), Securities Purchase Agreement (Origin Bancorp, Inc.)
Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, in Rule 144(i)144(i)(1) of the 0000 Xxx.
Appears in 6 contracts
Samples: Securities Purchase Agreement (Axion Power International, Inc.), Securities Purchase Agreement (Uni-Pixel), Securities Purchase Agreement (Banro Corp)
Shell Company Status. The Company is not, and has never been, not an issuer identified in, or and subject to, Rule 144(i).
Appears in 6 contracts
Samples: Securities Purchase Agreement (Armata Pharmaceuticals, Inc.), Securities Purchase Agreement (Armata Pharmaceuticals, Inc.), Securities Purchase Agreement (Entasis Therapeutics Holdings Inc.)
Shell Company Status. The Company is not a shell company, and is not, and has never been, an issuer identified in, or subject to, in Rule 144(i144(i)(1).
Appears in 5 contracts
Samples: Warrant Purchase Agreement (Corcept Therapeutics Inc), Common Stock Purchase Agreement (Cinedigm Digital Cinema Corp.), Warrant Purchase Agreement (Corcept Therapeutics Inc)
Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, in Rule 144(i), and Rule 144(i) has never applied to the Company.
Appears in 5 contracts
Samples: Subscription Agreement (ARCA Biopharma, Inc.), Subscription Agreement (ARCA Biopharma, Inc.), Subscription Agreement (Atlas Venture Fund VII L P)
Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, paragraph (i) of Rule 144(i)144.
Appears in 5 contracts
Samples: Securities Purchase Agreement (Inpixon), Securities Purchase Agreement (U.S. Stem Cell, Inc.), Securities Purchase Agreement (Bioheart, Inc.)
Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, Rule 144(i)) of the 0000 Xxx.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Aradigm Corp), Stock Purchase Agreement (Aradigm Corp), Securities Purchase Agreement (Aradigm Corp)
Shell Company Status. The Company is not, and has never been, not an issuer identified in, or subject to, Rule 144(i).
Appears in 3 contracts
Samples: Securities Purchase Agreement (Alpha Cognition Inc.), Securities Purchase Agreement (Alpha Cognition Inc.), Securities Purchase Agreement (Q BioMed Inc.)
Shell Company Status. The Company is not, and to the knowledge of the Company, has never been, an issuer identified in, or subject to, Rule 144(i)144(i)(1) of the Securities Act.
Appears in 3 contracts
Samples: Subscription Agreement (Luna Innovations Inc), Exchange Agreement (Comtech Telecommunications Corp /De/), Subscription Agreement (Comtech Telecommunications Corp /De/)
Shell Company Status. The Company is not, and has never beennot previously been at any time, an issuer identified in, or subject to, Rule 144(i).
Appears in 3 contracts
Samples: Common Stock Purchase Agreement (Lucid Diagnostics Inc.), Ordinary Share Purchase Agreement (TH International LTD), Common Shares Purchase Agreement (Roivant Sciences Ltd.)
Shell Company Status. The Company is not, not presently and has never been, been an issuer identified in, or subject to, as a “Shell Company” and otherwise complies with Rule 144(i).
Appears in 2 contracts
Samples: Securities Purchase Agreement (Biohitech Global, Inc.), Securities Purchase Agreement (Biohitech Global, Inc.)
Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, Rule 144(i).) of the Securities Act.
Appears in 2 contracts
Samples: Exchange Agreement (Kiromic Biopharma, Inc.), Exchange Agreement (Kiromic Biopharma, Inc.)
Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, Rule 144(i) promulgated under the Securities Act (or a successor rule) (“Rule 144”).
Appears in 2 contracts
Samples: Subscription Agreement, Subscription Agreement (Originclear, Inc.)
Shell Company Status. The Since January 1, 2010, the Company is not, and has never been, not an issuer identified in, or subject to, Rule 144(i).
Appears in 2 contracts
Samples: Exchange Agreement (SANUWAVE Health, Inc.), Securities Purchase Agreement (SANUWAVE Health, Inc.)
Shell Company Status. The Company is not, and has never been, been an issuer identified in, or subject to, described in Rule 144(i144(i)(1)(i).
Appears in 2 contracts
Samples: Securities Purchase Agreement (Niocorp Developments LTD), Securities Purchase Agreement (Niocorp Developments LTD)
Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, in SEC Rule 144(i144(i)(1).
Appears in 2 contracts
Samples: Stock Purchase Agreement (Jacksonville Bancorp Inc /Fl/), Stock Purchase Agreement (Jacksonville Bancorp Inc /Fl/)
Shell Company Status. The Company is not, not and has never been, been an issuer identified in, or subject to, in Rule 144(i)144(i)(1) of the Securities Act.
Appears in 1 contract
Samples: Subscription Agreement (Drone Aviation Holding Corp.)
Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, Rule 144(i)144(i)(1) of the Securities Act and is not an “ineligible issuer” as defined in the Securities Act.
Appears in 1 contract
Shell Company Status. The Company is not, and has never not, since 1998, been, an issuer identified in, or subject to, in Rule 144(i144(i)(1).
Appears in 1 contract
Samples: Securities Purchase Agreement (Generex Biotechnology Corp)
Shell Company Status. The Company is not, and, except as described in the Registration Statement and the Prospectus, has never been, an issuer identified in, or subject to, in Rule 144(i144(i)(1).
Appears in 1 contract
Shell Company Status. The Company is not, and since at least 2008 has never been, an issuer identified in, or subject to, Rule 144(i).
Appears in 1 contract
Shell Company Status. The Company is not, not and has never been, an issuer identified in, or subject to, in Securities Act Rule 144(i144(i)(1).
Appears in 1 contract
Samples: Securities Purchase Agreement (Z Trim Holdings, Inc)
Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, Rule 144(i)..
Appears in 1 contract
Samples: Securities Purchase Agreement (Mullen Automotive Inc.)
Shell Company Status. The Company is notnot currently, and has never been, an issuer identified in, or subject to, in Rule 144(i)144(i)(1) under the 0000 Xxx.
Appears in 1 contract
Samples: Securities Purchase Agreement (Parnell Pharmaceuticals Holdings LTD)
Shell Company Status. The Company is not, not and has never been, not been an issuer identified in, or subject to, in Rule 144(i144(i)(1).
Appears in 1 contract
Samples: Security Purchase Agreement (Blue Water Global Group, Inc.)
Shell Company Status. The Company is notnot now, and has never been, an issuer identified in, or subject to, Rule 144(i).
Appears in 1 contract
Samples: Securities Purchase Agreement (Magnum dOr Resources Inc)
Shell Company Status. The Company is notnot and, and to the best of the Company’s knowledge, has never been, been an issuer identified in, or subject to, in Rule 144(i144(i)(1).
Appears in 1 contract
Samples: Securities Purchase Agreement (Quest Patent Research Corp)
Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, described in Rule 144(i144(i)(1)(i).
Appears in 1 contract
Samples: Standby Equity Purchase Agreement (Niocorp Developments LTD)
Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, Rule 144(i)) promulgated under the U.S. Securities Act.
Appears in 1 contract
Samples: Subscription Agreement (Trillium Therapeutics Inc.)
Shell Company Status. The Company is not, and has never been, been and is not currently an issuer identified in, or subject to, in Rule 144(i)144(i)(1)(i) under the Securities Act.
Appears in 1 contract
Samples: Investment and Restructuring Agreement (Vicapsys Life Sciences, Inc.)
Shell Company Status. The Company is notnot currently, and has never been, an issuer identified in, or subject to, in Rule 144(i144(i)(1).
Appears in 1 contract
Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, Rule 144(i).
Appears in 1 contract
Samples: Securities Purchase Agreement (True Drinks Holdings, Inc.)
Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, contemplated by Rule 144(i144(i)(1).
Appears in 1 contract
Samples: Securities Purchase Agreement (Selecta Biosciences Inc)
Shell Company Status. The Company is not, not and has never been, not been at any time previously an issuer identified in, or subject to, described in paragraph (i)(1) of Rule 144(i)144.
Appears in 1 contract
Samples: Subscription Agreement (Texas Rare Earth Resources Corp.)